Bridgeway Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $64K | Hold |
|
|||||
|
2025
Q2 | $56K | Sell |
|
|||||
|
2025
Q1 | $121K | Sell |
|
|||||
|
2024
Q4 | $95.4K | Sell |
|
|||||
|
2024
Q3 | $145K | Sell |
|
|||||
|
2024
Q2 | $621K | Hold |
|
|||||
|
2024
Q1 | $657K | Hold |
|
|||||
|
2023
Q4 | $427K | Buy |
|
|||||
|
2023
Q3 | $379K | Hold |
|
|||||
|
2023
Q2 | $475K | Hold |
|
|||||
|
2023
Q1 | $604K | Sell |
|
|||||
|
2022
Q4 | $947K | Hold |
|
|||||
|
2022
Q3 | $657K | Hold |
|
|||||
|
2022
Q2 | $428K | Hold |
|
|||||
|
2022
Q1 | $455K | Hold |
|
|||||
|
2021
Q4 | $535K | Buy |
|
|||||
|
2021
Q3 | $701K | Sell |
|
|||||
|
2021
Q2 | $784K | Buy |
|
|||||
|
2021
Q1 | $643K | Buy |
|
|||||
|
2020
Q4 | $537K | Buy |
|
|||||
|
2020
Q3 | $648K | Buy |
|
|||||
|
2020
Q2 | $97K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $8K | Hold |
|
|||||
|
2019
Q1 | $15K | Hold |
|
|||||
|
2018
Q4 | $12K | Sell |
|
|||||
|
2018
Q3 | $128K | Hold |
|
|||||
|
2018
Q2 | $110K | Hold |
|
|||||
|
2018
Q1 | $63K | Hold |
|
|||||
|
2017
Q4 | $114K | Hold |
|
|||||
|
2017
Q3 | $99K | Sell |
|
|||||
|
2017
Q2 | $393K | Buy |
|
|||||
|
2017
Q1 | $363K | Hold |
|
|||||
|
2016
Q4 | $210K | Hold |
|
|||||
|
2016
Q3 | $324K | Hold |
|
|||||
|
2016
Q2 | $425K | Hold |
|
|||||
|
2016
Q1 | $478K | Buy |
|
|||||
|
2015
Q4 | $517K | Hold |
|
|||||
|
2015
Q3 | $284K | Buy |
|
|||||
|
2015
Q2 | $302K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $301K | Sell |
|
|||||
|
2014
Q3 | $388K | Buy |
|
|||||
|
2014
Q2 | $204K | Buy |
|